Skip to main content
Erschienen in: Neurotherapeutics 2/2014

01.04.2014 | Review

Mechanisms of Epileptogenesis in Pediatric Epileptic Syndromes: Rasmussen Encephalitis, Infantile Spasms, and Febrile Infection-related Epilepsy Syndrome (FIRES)

verfasst von: Carlos A. Pardo, Rima Nabbout, Aristea S. Galanopoulou

Erschienen in: Neurotherapeutics | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The mechanisms of epileptogenesis in pediatric epileptic syndromes are diverse, and may involve disturbances of neurodevelopmental trajectories, synaptic homeostasis, and cortical connectivity, which may occur during brain development, early infancy, or childhood. Although genetic or structural/metabolic factors are frequently associated with age-specific epileptic syndromes, such as infantile spasms and West syndrome, other syndromes may be determined by the effect of immunopathogenic mechanisms or energy-dependent processes in response to environmental challenges, such as infections or fever in normally-developed children during early or late childhood. Immune-mediated mechanisms have been suggested in selected pediatric epileptic syndromes in which acute and rapidly progressive encephalopathies preceded by fever and/or infections, such as febrile infection-related epilepsy syndrome, or in chronic progressive encephalopathies, such as Rasmussen encephalitis. A definite involvement of adaptive and innate immune mechanisms driven by cytotoxic CD8+ T lymphocytes and neuroglial responses has been demonstrated in Rasmussen encephalitis, although the triggering factor of these responses remains unknown. Although the beneficial response to steroids and adrenocorticotropic hormone of infantile spasms, or preceding fever or infection in FIRES, may support a potential role of neuroinflammation as pathogenic factor, no definite demonstration of such involvement has been achieved, and genetic or metabolic factors are suspected. A major challenge for the future is discovering pathogenic mechanisms and etiological factors that facilitate the introduction of novel targets for drug intervention aimed at interfering with the disease mechanisms, therefore providing putative disease-modifying treatments in these pediatric epileptic syndromes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51:2175-2189.PubMed Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51:2175-2189.PubMed
2.
Zurück zum Zitat Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011;45:355-367.PubMedCentralPubMed Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011;45:355-367.PubMedCentralPubMed
3.
Zurück zum Zitat Epi4K Consortium, Epilepsy Phenome/Genome P, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501:217-221.PubMed Epi4K Consortium, Epilepsy Phenome/Genome P, Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501:217-221.PubMed
4.
Zurück zum Zitat Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125:1751-1759.PubMed Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125:1751-1759.PubMed
5.
Zurück zum Zitat Nabbout R. FIRES and IHHE: Delineation of the syndromes. Epilepsia. 2013;54(Suppl.) 6:54-56 Nabbout R. FIRES and IHHE: Delineation of the syndromes. Epilepsia. 2013;54(Suppl.) 6:54-56
6.
Zurück zum Zitat Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8:435-445.PubMed Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8:435-445.PubMed
7.
Zurück zum Zitat Freeman JM. Rasmussen's syndrome: progressive autoimmune multi-focal encephalopathy. Pediatr Neurol 2005;32:295-299.PubMed Freeman JM. Rasmussen's syndrome: progressive autoimmune multi-focal encephalopathy. Pediatr Neurol 2005;32:295-299.PubMed
8.
Zurück zum Zitat Gordon N. Rasmussen's encephalitis. Develop Med Child Neurol 1997;39:133-136.PubMed Gordon N. Rasmussen's encephalitis. Develop Med Child Neurol 1997;39:133-136.PubMed
9.
Zurück zum Zitat Bien CG, Tiemeier H, Sassen R, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013;54:543-550.PubMed Bien CG, Tiemeier H, Sassen R, et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013;54:543-550.PubMed
10.
Zurück zum Zitat Lamb K, Scott W, Mensah A, et al. Incidence, prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom. Epilepsia 54(Suppl.3):4. Lamb K, Scott W, Mensah A, et al. Incidence, prevalence and clinical outcome of Rasmussen encephalitis in children from the United Kingdom. Epilepsia 54(Suppl.3):4.
11.
Zurück zum Zitat Granata T, Andermann F. Rasmussen encephalitis. Handbook Clin Neurol 2012;111:511-519. Granata T, Andermann F. Rasmussen encephalitis. Handbook Clin Neurol 2012;111:511-519.
12.
Zurück zum Zitat Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004;45:516-526.PubMed Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004;45:516-526.PubMed
13.
Zurück zum Zitat Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005;128:454-471.PubMed Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005;128:454-471.PubMed
14.
Zurück zum Zitat Olson HE, Lechpammer M, Prabhu SP, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 2013;54:1753-1760.PubMed Olson HE, Lechpammer M, Prabhu SP, et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 2013;54:1753-1760.PubMed
15.
Zurück zum Zitat Varadkar SM, Bien CG, Kruse CK, et al. Rasmussen encephalitis: current concepts and therapeutic advances. Lancet Neurol 2014 (in press). Varadkar SM, Bien CG, Kruse CK, et al. Rasmussen encephalitis: current concepts and therapeutic advances. Lancet Neurol 2014 (in press).
16.
Zurück zum Zitat Longaretti F, Dunkley C, Varadkar S, Vargha-Khadem F, Boyd SG, Cross JH. Evolution of the EEG in children with Rasmussen’s syndrome. Epilepsia 2012;53:1539-1545.PubMed Longaretti F, Dunkley C, Varadkar S, Vargha-Khadem F, Boyd SG, Cross JH. Evolution of the EEG in children with Rasmussen’s syndrome. Epilepsia 2012;53:1539-1545.PubMed
17.
Zurück zum Zitat Yacubian EM, Marie SK, Valerio RM, Jorge CL, Yamaga L, Buchpiguel CA. Neuroimaging findings in Rasmussen's syndrome. J Neuroimag 1997;7:16-22. Yacubian EM, Marie SK, Valerio RM, Jorge CL, Yamaga L, Buchpiguel CA. Neuroimaging findings in Rasmussen's syndrome. J Neuroimag 1997;7:16-22.
18.
Zurück zum Zitat Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002;58:250-257.PubMed Bien CG, Urbach H, Deckert M, et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002;58:250-257.PubMed
19.
Zurück zum Zitat Kim SJ, Park YD, Pillai JJ, Lee MR, Smith JR. A longitudinal MRI study in children with Rasmussen syndrome. Pediatr Neurol 2002;27:282-288.PubMed Kim SJ, Park YD, Pillai JJ, Lee MR, Smith JR. A longitudinal MRI study in children with Rasmussen syndrome. Pediatr Neurol 2002;27:282-288.PubMed
20.
Zurück zum Zitat Bien CG, Gleissner U, Sassen R, Widman G, Urbach H, Elger CE. An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 2004;62:2106-2109.PubMed Bien CG, Gleissner U, Sassen R, Widman G, Urbach H, Elger CE. An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 2004;62:2106-2109.PubMed
21.
Zurück zum Zitat Wagner J, Schoene-Bake J-C, Bien CG, Urbach H, Elger CE, Weber B. Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis. Epilepsia 2012;53:613-621.PubMed Wagner J, Schoene-Bake J-C, Bien CG, Urbach H, Elger CE, Weber B. Automated 3D MRI volumetry reveals regional atrophy differences in Rasmussen encephalitis. Epilepsia 2012;53:613-621.PubMed
22.
Zurück zum Zitat Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair A. 18F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. AJNR Am J Neuroradiol 2001;22:1291–1299.PubMed Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair A. 18F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. AJNR Am J Neuroradiol 2001;22:1291–1299.PubMed
23.
Zurück zum Zitat Farrell MA, DeRosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992;83:246-259.PubMed Farrell MA, DeRosa MJ, Curran JG, et al. Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 1992;83:246-259.PubMed
24.
Zurück zum Zitat Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vinters HV. Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol 1995;89:313-321.PubMed Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vinters HV. Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol 1995;89:313-321.PubMed
25.
Zurück zum Zitat Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002;51:311-318.PubMed Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002;51:311-318.PubMed
26.
Zurück zum Zitat Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis. J Neuroinflammation 2013;10:152.PubMedCentralPubMed Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis. J Neuroinflammation 2013;10:152.PubMedCentralPubMed
27.
Zurück zum Zitat Schwab N, Bien CG, Waschbisch A, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009;132:1236-1246.PubMed Schwab N, Bien CG, Waschbisch A, et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009;132:1236-1246.PubMed
28.
Zurück zum Zitat Owens GC, Huynh MN, Chang JW, et al. Differential expression of interferon-gamma and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation 2013;10:56.PubMedCentralPubMed Owens GC, Huynh MN, Chang JW, et al. Differential expression of interferon-gamma and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response. J Neuroinflammation 2013;10:56.PubMedCentralPubMed
29.
Zurück zum Zitat Bernasconi P, Antozzi C, Granata T, Spreafico R, Mantegazza R. Rasmussen's encephalitis: update on pathogenesis and treatment. Exp Rev Neurother 2003;3:835-843. Bernasconi P, Antozzi C, Granata T, Spreafico R, Mantegazza R. Rasmussen's encephalitis: update on pathogenesis and treatment. Exp Rev Neurother 2003;3:835-843.
30.
Zurück zum Zitat Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 2009;86:101-112.PubMed Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 2009;86:101-112.PubMed
31.
Zurück zum Zitat Vining EP, Freeman JM, Brandt J, Carson BS, Uematsu S. Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal. Epilepsia 1993;34:639-650.PubMed Vining EP, Freeman JM, Brandt J, Carson BS, Uematsu S. Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal. Epilepsia 1993;34:639-650.PubMed
32.
Zurück zum Zitat Pulsifer MB, Brandt J, Salorio CF, Vining EP, Carson BS, Freeman JM. The cognitive outcome of hemispherectomy in 71 children. Epilepsia 2004;45:243-254.PubMed Pulsifer MB, Brandt J, Salorio CF, Vining EP, Carson BS, Freeman JM. The cognitive outcome of hemispherectomy in 71 children. Epilepsia 2004;45:243-254.PubMed
33.
Zurück zum Zitat Carson BS, Javedan SP, Freeman JM, et al. Hemispherectomy: a hemidecortication approach and review of 52 cases. J Neurosurg 1996;84:903-911.PubMed Carson BS, Javedan SP, Freeman JM, et al. Hemispherectomy: a hemidecortication approach and review of 52 cases. J Neurosurg 1996;84:903-911.PubMed
34.
Zurück zum Zitat Bittner S, Simon OJ, Göbel K, Bien CG, Meuth SG, Wiendl H. Rasmussen encephalitis treated with natalizumab. Neurology 2013;81:395–397.PubMed Bittner S, Simon OJ, Göbel K, Bien CG, Meuth SG, Wiendl H. Rasmussen encephalitis treated with natalizumab. Neurology 2013;81:395–397.PubMed
35.
36.
Zurück zum Zitat Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.PubMed Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-651.PubMed
37.
Zurück zum Zitat Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001;57:1511-1514.PubMed Wiendl H, Bien CG, Bernasconi P, et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001;57:1511-1514.PubMed
38.
Zurück zum Zitat Yang R, Puranam RS, Butler LS, et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000;28:375-383.PubMed Yang R, Puranam RS, Butler LS, et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000;28:375-383.PubMed
39.
Zurück zum Zitat Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010;23:144-150.PubMed Vincent A, Irani SR, Lang B. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 2010;23:144-150.PubMed
40.
Zurück zum Zitat Greiner H, Leach JL, Lee K-H, Krueger DA. Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 2011;20:266-270.PubMed Greiner H, Leach JL, Lee K-H, Krueger DA. Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 2011;20:266-270.PubMed
41.
Zurück zum Zitat Granata T, Fusco L, Gobbi G, et al. Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology 2003;61:1807-1810.PubMed Granata T, Fusco L, Gobbi G, et al. Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology 2003;61:1807-1810.PubMed
42.
Zurück zum Zitat Laxer KD, Wilfong A, Morris III G, Andermann F. Pilot study of Rituximab to treat chronic focal encepahlitis. American Epilepsy Society Annual Conference 2008, Abst 1.277. Laxer KD, Wilfong A, Morris III G, Andermann F. Pilot study of Rituximab to treat chronic focal encepahlitis. American Epilepsy Society Annual Conference 2008, Abst 1.277.
43.
Zurück zum Zitat Thilo B, Stingele R, Knudsen K, et al. A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol 2009;5:458-462.PubMed Thilo B, Stingele R, Knudsen K, et al. A case of Rasmussen encephalitis treated with rituximab. Nat Rev Neurol 2009;5:458-462.PubMed
44.
Zurück zum Zitat Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Ann Rev Immunol 2009;27:119-145. Ransohoff RM, Perry VH. Microglial physiology: unique stimuli, specialized responses. Ann Rev Immunol 2009;27:119-145.
45.
Zurück zum Zitat Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handbook Clin Neurol 2012;107:163-175. Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handbook Clin Neurol 2012;107:163-175.
46.
Zurück zum Zitat Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803.PubMed Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803.PubMed
47.
Zurück zum Zitat Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012;74:691-705.PubMedCentralPubMed Schafer DP, Lehrman EK, Kautzman AG, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012;74:691-705.PubMedCentralPubMed
48.
Zurück zum Zitat Ransohoff RM, Stevens B. Neuroscience. How many cell types does it take to wire a brain? Science 2011;333:1391-1392.PubMed Ransohoff RM, Stevens B. Neuroscience. How many cell types does it take to wire a brain? Science 2011;333:1391-1392.PubMed
49.
Zurück zum Zitat Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012;72:881-892.PubMed Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012;72:881-892.PubMed
50.
51.
Zurück zum Zitat Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007;62:67-80.PubMed Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007;62:67-80.PubMed
52.
Zurück zum Zitat Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 2004;4:193-205.PubMed Swanson RA, Ying W, Kauppinen TM. Astrocyte influences on ischemic neuronal death. Curr Mol Med 2004;4:193-205.PubMed
53.
Zurück zum Zitat Rasmussen T. Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol 1978;41:1-12.PubMed Rasmussen T. Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol 1978;41:1-12.PubMed
54.
Zurück zum Zitat Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet 1989;1:279-280.PubMed Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet 1989;1:279-280.PubMed
55.
Zurück zum Zitat Power C, Poland S, Blume W, Girvin J, Rice G. Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990;336:1282-1284.PubMed Power C, Poland S, Blume W, Girvin J, Rice G. Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990;336:1282-1284.PubMed
56.
Zurück zum Zitat Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Human Pathol 1993;24:871-879. Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Human Pathol 1993;24:871-879.
57.
Zurück zum Zitat Jay V, Becker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995;45:108-117.PubMed Jay V, Becker LE, Otsubo H, et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995;45:108-117.PubMed
58.
Zurück zum Zitat Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol 1995;14:7-12.PubMed Atkins MR, Terrell W, Hulette CM. Rasmussen's syndrome: a study of potential viral etiology. Clin Neuropathol 1995;14:7-12.PubMed
59.
Zurück zum Zitat Ohmori I, Ouchida M, Kobayashi K, et al. Rasmussen encephalitis associated with SCN 1 A mutation. Epilepsia 2008;49:521-526.PubMed Ohmori I, Ouchida M, Kobayashi K, et al. Rasmussen encephalitis associated with SCN 1 A mutation. Epilepsia 2008;49:521-526.PubMed
60.
Zurück zum Zitat Alvarez-Baron E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res 2008;80:93-97.PubMed Alvarez-Baron E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res 2008;80:93-97.PubMed
61.
Zurück zum Zitat Deprez L, Weckhuysen S, Holmgren P, et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology 2010;75:1159-1165.PubMed Deprez L, Weckhuysen S, Holmgren P, et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology 2010;75:1159-1165.PubMed
62.
Zurück zum Zitat Weckhuysen S, Holmgren P, Hendrickx R, et al. Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia 2013;54:e74-e80.PubMed Weckhuysen S, Holmgren P, Hendrickx R, et al. Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia 2013;54:e74-e80.PubMed
63.
Zurück zum Zitat Hart YM, Andermann F, Robitaille Y, Laxer KD, Rasmussen T, Davis R. Double pathology in Rasmussen's syndrome: a window on the etiology? Neurology 1998;50:731-735.PubMed Hart YM, Andermann F, Robitaille Y, Laxer KD, Rasmussen T, Davis R. Double pathology in Rasmussen's syndrome: a window on the etiology? Neurology 1998;50:731-735.PubMed
64.
Zurück zum Zitat Takei H, Wilfong A, Malphrus A, et al. Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature. Neuropathology 2010;30:381-391.PubMed Takei H, Wilfong A, Malphrus A, et al. Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature. Neuropathology 2010;30:381-391.PubMed
65.
Zurück zum Zitat Wang D, Blumcke I, Gui Q, et al. Clinico-pathological investigations of Rasmussen encephalitis suggest multifocal disease progression and associated focal cortical dysplasia. Epileptic Disord 2013;15:32-43.PubMed Wang D, Blumcke I, Gui Q, et al. Clinico-pathological investigations of Rasmussen encephalitis suggest multifocal disease progression and associated focal cortical dysplasia. Epileptic Disord 2013;15:32-43.PubMed
66.
Zurück zum Zitat Vining EP, Freeman JM, Pillas DJ, et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomy-the Johns Hopkins experience: 1968 to 1996. Pediatrics 1997;100:163-171.PubMed Vining EP, Freeman JM, Pillas DJ, et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomy-the Johns Hopkins experience: 1968 to 1996. Pediatrics 1997;100:163-171.PubMed
67.
68.
Zurück zum Zitat Hrachovy RA. West's syndrome (infantile spasms). Clinical description and diagnosis. Adv Exp Med Biol 2002;497:33-50.PubMed Hrachovy RA. West's syndrome (infantile spasms). Clinical description and diagnosis. Adv Exp Med Biol 2002;497:33-50.PubMed
69.
Zurück zum Zitat West WJ. On a peculiar form of infantile convulsions. Lancet 1841;35:724-725. West WJ. On a peculiar form of infantile convulsions. Lancet 1841;35:724-725.
70.
Zurück zum Zitat Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62:1668-1681.PubMedCentralPubMed Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004;62:1668-1681.PubMedCentralPubMed
71.
Zurück zum Zitat Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012;78:1974-1980.PubMedCentralPubMed Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012;78:1974-1980.PubMedCentralPubMed
72.
Zurück zum Zitat Mytinger JR, Joshi S. The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. J Child Neurol 2012;27:1289-1294.PubMed Mytinger JR, Joshi S. The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. J Child Neurol 2012;27:1289-1294.PubMed
73.
Zurück zum Zitat Osborne JP, Lux AL, Edwards SW, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia 2010;51:2168-2174.PubMed Osborne JP, Lux AL, Edwards SW, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia 2010;51:2168-2174.PubMed
74.
Zurück zum Zitat Mefford HC, Yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol 2011;70:974-985.PubMedCentralPubMed Mefford HC, Yendle SC, Hsu C, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol 2011;70:974-985.PubMedCentralPubMed
75.
Zurück zum Zitat Friocourt G, Parnavelas JG. Mutations in ARX result in several defects involving GABAergic neurons. Front Cell Neurosci 2010;4:4.PubMedCentralPubMed Friocourt G, Parnavelas JG. Mutations in ARX result in several defects involving GABAergic neurons. Front Cell Neurosci 2010;4:4.PubMedCentralPubMed
76.
Zurück zum Zitat Beguin S, Crepel V, Aniksztejn L, et al. An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development. Cereb Cortex 2013;23:1484-1494.PubMed Beguin S, Crepel V, Aniksztejn L, et al. An epilepsy-related ARX polyalanine expansion modifies glutamatergic neurons excitability and morphology without affecting GABAergic neurons development. Cereb Cortex 2013;23:1484-1494.PubMed
77.
Zurück zum Zitat Olivetti PR, Noebels JL. Interneuron, interrupted: molecular pathogenesis of ARX mutations and X-linked infantile spasms. Curr Opin Neurobiol 2012;22:859-865.PubMedCentralPubMed Olivetti PR, Noebels JL. Interneuron, interrupted: molecular pathogenesis of ARX mutations and X-linked infantile spasms. Curr Opin Neurobiol 2012;22:859-865.PubMedCentralPubMed
78.
Zurück zum Zitat Price MG, Yoo JW, Burgess DL, et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 2009;29:8752-8763.PubMedCentralPubMed Price MG, Yoo JW, Burgess DL, et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci 2009;29:8752-8763.PubMedCentralPubMed
79.
Zurück zum Zitat Marsh E, Fulp C, Gomez E, et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009;132:1563-1576.PubMedCentralPubMed Marsh E, Fulp C, Gomez E, et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 2009;132:1563-1576.PubMedCentralPubMed
80.
Zurück zum Zitat Galanopoulou AS. Basic mechanisms of catastrophic epilepsy—overview from animal models. Brain Dev 2013;35:748-756.PubMed Galanopoulou AS. Basic mechanisms of catastrophic epilepsy—overview from animal models. Brain Dev 2013;35:748-756.PubMed
81.
Zurück zum Zitat Toonen RF, Wierda K, Sons MS, et al. Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. Proc Natl Acad Sci U S A 2006;103:18332-18337.PubMedCentralPubMed Toonen RF, Wierda K, Sons MS, et al. Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. Proc Natl Acad Sci U S A 2006;103:18332-18337.PubMedCentralPubMed
82.
Zurück zum Zitat Nabbout R, Melki I, Gerbaka B, Dulac O, Akatcherian C. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001;42:1580-1583.PubMed Nabbout R, Melki I, Gerbaka B, Dulac O, Akatcherian C. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001;42:1580-1583.PubMed
83.
Zurück zum Zitat Lujic L, Bosnjak VM, Delin S, Duranovic V, Krakar G. Infantile spasms in children with Down syndrome. Coll Antropol 2011;35(Suppl. 1):213-218.PubMed Lujic L, Bosnjak VM, Delin S, Duranovic V, Krakar G. Infantile spasms in children with Down syndrome. Coll Antropol 2011;35(Suppl. 1):213-218.PubMed
84.
Zurück zum Zitat Sanmaneechai O, Sogawa Y, Silver W, Ballaban-Gil K, Moshe SL, Shinnar S. Treatment outcomes of West syndrome in infants with Down syndrome. Pediatr Neurol 2013;48:42-47.PubMed Sanmaneechai O, Sogawa Y, Silver W, Ballaban-Gil K, Moshe SL, Shinnar S. Treatment outcomes of West syndrome in infants with Down syndrome. Pediatr Neurol 2013;48:42-47.PubMed
85.
Zurück zum Zitat Goldberg-Stern H, Strawsburg RH, Patterson B, et al. Seizure frequency and characteristics in children with Down syndrome. Brain Dev 2001;23:375-378.PubMed Goldberg-Stern H, Strawsburg RH, Patterson B, et al. Seizure frequency and characteristics in children with Down syndrome. Brain Dev 2001;23:375-378.PubMed
86.
Zurück zum Zitat Cortez MA, Shen L, Wu Y, et al. Infantile spasms and Down syndrome: a new animal model. Pediatr Res 2009;65:499-503.PubMed Cortez MA, Shen L, Wu Y, et al. Infantile spasms and Down syndrome: a new animal model. Pediatr Res 2009;65:499-503.PubMed
87.
Zurück zum Zitat Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010;51:1236-1241.PubMedCentralPubMed Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010;51:1236-1241.PubMedCentralPubMed
88.
Zurück zum Zitat Sidenvall R, Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36:572-574.PubMed Sidenvall R, Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36:572-574.PubMed
89.
Zurück zum Zitat Curatolo P, Seri S, Verdecchia M, Bombardieri R. Infantile spasms in tuberous sclerosis complex. Brain Dev 2001;23:502-507.PubMed Curatolo P, Seri S, Verdecchia M, Bombardieri R. Infantile spasms in tuberous sclerosis complex. Brain Dev 2001;23:502-507.PubMed
90.
Zurück zum Zitat Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-541.PubMed Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-541.PubMed
91.
Zurück zum Zitat Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure 2009;18:197-201.PubMed Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L. A retrospective study on aetiology based outcome of infantile spasms. Seizure 2009;18:197-201.PubMed
92.
Zurück zum Zitat Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol 2010;14:146-149.PubMed Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol 2010;14:146-149.PubMed
93.
Zurück zum Zitat Cross JH. Neurocutaneous syndromes and epilepsy-issues in diagnosis and management. Epilepsia 2005;46(Suppl. 10):17-23.PubMed Cross JH. Neurocutaneous syndromes and epilepsy-issues in diagnosis and management. Epilepsia 2005;46(Suppl. 10):17-23.PubMed
94.
Zurück zum Zitat Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012;74:41-48.PubMedCentralPubMed Poduri A, Evrony GD, Cai X, et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012;74:41-48.PubMedCentralPubMed
95.
Zurück zum Zitat Baek ST, Gibbs EM, Gleeson JG, Mathern GW. Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders. Curr Opin Neurol 2013;26:122-127.PubMed Baek ST, Gibbs EM, Gleeson JG, Mathern GW. Hemimegalencephaly, a paradigm for somatic postzygotic neurodevelopmental disorders. Curr Opin Neurol 2013;26:122-127.PubMed
96.
Zurück zum Zitat Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012;44:941-945.PubMed Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012;44:941-945.PubMed
97.
Zurück zum Zitat Orlova KA, Parker WE, Heuer GG, et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 2010;120:1591-1602.PubMedCentralPubMed Orlova KA, Parker WE, Heuer GG, et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 2010;120:1591-1602.PubMedCentralPubMed
98.
Zurück zum Zitat Parker WE, Orlova KA, Parker WH, et al. Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sc Transl Med 2013;5:182ra53. Parker WE, Orlova KA, Parker WH, et al. Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Sc Transl Med 2013;5:182ra53.
99.
Zurück zum Zitat Puffenberger EG, Strauss KA, Ramsey KE, et al. Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain 2007;130:1929-1941.PubMed Puffenberger EG, Strauss KA, Ramsey KE, et al. Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain 2007;130:1929-1941.PubMed
100.
Zurück zum Zitat Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.PubMed Becker AJ, Urbach H, Scheffler B, et al. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis. Ann Neurol 2002;52:29-37.PubMed
101.
Zurück zum Zitat Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-487.PubMed Baybis M, Yu J, Lee A, et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 2004;56:478-487.PubMed
102.
Zurück zum Zitat Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 2004;56:510-519.PubMed Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 2004;56:510-519.PubMed
103.
Zurück zum Zitat Lu Z, Hu X, Li Y, et al. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem 2004;279:35664-35670.PubMed Lu Z, Hu X, Li Y, et al. Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin. J Biol Chem 2004;279:35664-35670.PubMed
104.
Zurück zum Zitat Spangle JM, Munger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010;84:9398-9407.PubMedCentralPubMed Spangle JM, Munger K. The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 2010;84:9398-9407.PubMedCentralPubMed
105.
Zurück zum Zitat Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 2011;43:322-329.PubMedCentralPubMed Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 2011;43:322-329.PubMedCentralPubMed
106.
Zurück zum Zitat Shiihara T, Miyashita M, Yoshizumi M, Watanabe M, Yamada Y, Kato M. Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Dev 2010;32:695-702.PubMed Shiihara T, Miyashita M, Yoshizumi M, Watanabe M, Yamada Y, Kato M. Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Dev 2010;32:695-702.PubMed
107.
Zurück zum Zitat Haginoya K, Noguchi R, Zhao Y, et al. Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res 2009;85:314-317.PubMed Haginoya K, Noguchi R, Zhao Y, et al. Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res 2009;85:314-317.PubMed
108.
Zurück zum Zitat Yamanaka G, Kawashima H, Oana S, et al. Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome. J Neurol Sci 2010;298:106-109.PubMed Yamanaka G, Kawashima H, Oana S, et al. Increased level of serum interleukin-1 receptor antagonist subsequent to resolution of clinical symptoms in patients with West syndrome. J Neurol Sci 2010;298:106-109.PubMed
109.
Zurück zum Zitat Liu ZS, Wang QW, Wang FL, Yang LZ. Serum cytokine levels are altered in patients with West syndrome. Brain Dev 2001;23:548-551.PubMed Liu ZS, Wang QW, Wang FL, Yang LZ. Serum cytokine levels are altered in patients with West syndrome. Brain Dev 2001;23:548-551.PubMed
110.
Zurück zum Zitat Tekgul H, Polat M, Tosun A, Serdaroglu G, Kutukculer N, Gokben S. Cerebrospinal fluid interleukin-6 levels in patients with West syndrome. Brain Dev 2006;28:19-23.PubMed Tekgul H, Polat M, Tosun A, Serdaroglu G, Kutukculer N, Gokben S. Cerebrospinal fluid interleukin-6 levels in patients with West syndrome. Brain Dev 2006;28:19-23.PubMed
111.
Zurück zum Zitat Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshe SL. A model of symptomatic infantile spasms syndrome. Neurobiol Dis 2010;37:604-612.PubMedCentralPubMed Scantlebury MH, Galanopoulou AS, Chudomelova L, Raffo E, Betancourth D, Moshe SL. A model of symptomatic infantile spasms syndrome. Neurobiol Dis 2010;37:604-612.PubMedCentralPubMed
112.
Zurück zum Zitat Ono T, Briggs SW, Chudomelova L, Raffo E, Moshé SL, Galanopoulou AS. Intracortical injection of lipopolysaccharide induces epileptic spasms in neonatal rats: another animal model of symptomatic infantile spasms. Epilepsia 2012;12:300. Ono T, Briggs SW, Chudomelova L, Raffo E, Moshé SL, Galanopoulou AS. Intracortical injection of lipopolysaccharide induces epileptic spasms in neonatal rats: another animal model of symptomatic infantile spasms. Epilepsia 2012;12:300.
113.
Zurück zum Zitat Riikonen R. Infantile spasms: infectious disorders. Neuropediatrics 1993;24:274-280.PubMed Riikonen R. Infantile spasms: infectious disorders. Neuropediatrics 1993;24:274-280.PubMed
114.
Zurück zum Zitat Ohtaki E, Yamaguchi Y, Shiotsuki Y, et al. [A case with infantile spasms due to herpes simplex type 1 virus encephalitis]. No To Hattatsu 1987;19:502-506 [in Japanese].PubMed Ohtaki E, Yamaguchi Y, Shiotsuki Y, et al. [A case with infantile spasms due to herpes simplex type 1 virus encephalitis]. No To Hattatsu 1987;19:502-506 [in Japanese].PubMed
115.
Zurück zum Zitat Hackney JR, Harrison DK, Rozzelle C, Kankirawatana S, Kankirawatana P, Palmer CA. Chronic granulomatous herpes encephalitis in a child with clinically intractable epilepsy. Case Rep Pediatr 2012;2012:849812.PubMedCentralPubMed Hackney JR, Harrison DK, Rozzelle C, Kankirawatana S, Kankirawatana P, Palmer CA. Chronic granulomatous herpes encephalitis in a child with clinically intractable epilepsy. Case Rep Pediatr 2012;2012:849812.PubMedCentralPubMed
116.
Zurück zum Zitat Hattori H. Spontaneous remission of spasms in West syndrome—implications of viral infection. Brain Dev 2001;23:705-707.PubMed Hattori H. Spontaneous remission of spasms in West syndrome—implications of viral infection. Brain Dev 2001;23:705-707.PubMed
117.
Zurück zum Zitat Ono J, Imai K, Tanaka-Taya K, Kurahashi H, Okada S. Decreased frequency of seizures in infantile spasms associated with lissencephaly by human herpes virus 7 infection. Pediatr Int 2002;44:168-170.PubMed Ono J, Imai K, Tanaka-Taya K, Kurahashi H, Okada S. Decreased frequency of seizures in infantile spasms associated with lissencephaly by human herpes virus 7 infection. Pediatr Int 2002;44:168-170.PubMed
118.
Zurück zum Zitat Bonkowsky JL, Filloux FM, Byington CL. Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin. Pediatrics 2006;117:e1045-8.PubMed Bonkowsky JL, Filloux FM, Byington CL. Herpes simplex virus central nervous system relapse during treatment of infantile spasms with corticotropin. Pediatrics 2006;117:e1045-8.PubMed
119.
Zurück zum Zitat Mota NG, Rezkallah-Iwasso MT, Peracoli MT, Montelli TC. Demonstration of antibody and cellular immune response to brain extract in West and Lennox-Gastaut syndromes. Arq Neuropsiquiatr 1984;42:126-131.PubMed Mota NG, Rezkallah-Iwasso MT, Peracoli MT, Montelli TC. Demonstration of antibody and cellular immune response to brain extract in West and Lennox-Gastaut syndromes. Arq Neuropsiquiatr 1984;42:126-131.PubMed
120.
Zurück zum Zitat Suleiman J, Brenner T, Gill D, Troedson C, Sinclair AJ, Brilot F, et al. Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol 2011;53:1058-1060.PubMed Suleiman J, Brenner T, Gill D, Troedson C, Sinclair AJ, Brilot F, et al. Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol 2011;53:1058-1060.PubMed
121.
Zurück zum Zitat Steele SU, Cheah SM, Veerapandiyan A, Gallentine W, Smith EC, Mikati MA. Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency. Epilepsy Behav 2012;24:507-512.PubMed Steele SU, Cheah SM, Veerapandiyan A, Gallentine W, Smith EC, Mikati MA. Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency. Epilepsy Behav 2012;24:507-512.PubMed
122.
Zurück zum Zitat Frost JD, Jr, Hrachovy RA. Pathogenesis of infantile spasms: a model based on developmental desynchronization. J Clin Neurophysiol 2005;22:25-36.PubMed Frost JD, Jr, Hrachovy RA. Pathogenesis of infantile spasms: a model based on developmental desynchronization. J Clin Neurophysiol 2005;22:25-36.PubMed
123.
Zurück zum Zitat Lee CL, Frost JD, Jr, Swann JW, Hrachovy RA. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 2008;49:298-307.PubMed Lee CL, Frost JD, Jr, Swann JW, Hrachovy RA. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 2008;49:298-307.PubMed
124.
Zurück zum Zitat Mares P, Velisek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Develop Brain Res 1992;65:185-189. Mares P, Velisek L. N-methyl-D-aspartate (NMDA)-induced seizures in developing rats. Brain Res Develop Brain Res 1992;65:185-189.
125.
Zurück zum Zitat Kabova R, Liptakova S, Slamberova R, Pometlova M, Velisek L. Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 1999;40:1357-1369.PubMed Kabova R, Liptakova S, Slamberova R, Pometlova M, Velisek L. Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. Epilepsia 1999;40:1357-1369.PubMed
126.
Zurück zum Zitat Kabova R, Veresova S, Velisek L. West syndrome model: seek and you will find. Sb Lek 1997;98:115-126.PubMed Kabova R, Veresova S, Velisek L. West syndrome model: seek and you will find. Sb Lek 1997;98:115-126.PubMed
127.
Zurück zum Zitat Wang YJ, Zhang Y, Liang XH, Yang G, Zou LP. Effects of adrenal dysfunction and high-dose adrenocorticotropic hormone on NMDA-induced spasm seizures in young Wistar rats. Epilepsy Res 2012;100:125-131.PubMed Wang YJ, Zhang Y, Liang XH, Yang G, Zou LP. Effects of adrenal dysfunction and high-dose adrenocorticotropic hormone on NMDA-induced spasm seizures in young Wistar rats. Epilepsy Res 2012;100:125-131.PubMed
128.
Zurück zum Zitat Velisek L, Jehle K, Asche S, Veliskova J. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 2007;61:109-119.PubMed Velisek L, Jehle K, Asche S, Veliskova J. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain. Ann Neurol 2007;61:109-119.PubMed
129.
Zurück zum Zitat Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol 1993;33:231-236.PubMedCentralPubMed Baram TZ. Pathophysiology of massive infantile spasms: perspective on the putative role of the brain adrenal axis. Ann Neurol 1993;33:231-236.PubMedCentralPubMed
130.
Zurück zum Zitat Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Develop Brain Res 1991;61:97-101. Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Develop Brain Res 1991;61:97-101.
131.
Zurück zum Zitat Baram TZ, Schultz L. ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 1995;36:174-178.PubMedCentralPubMed Baram TZ, Schultz L. ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 1995;36:174-178.PubMedCentralPubMed
132.
Zurück zum Zitat Yum MS, Chachua T, Veliskova J, Velisek L. Prenatal stress promotes development of spasms in infant rats. Epilepsia 2012;53:e46-e49.PubMedCentralPubMed Yum MS, Chachua T, Veliskova J, Velisek L. Prenatal stress promotes development of spasms in infant rats. Epilepsia 2012;53:e46-e49.PubMedCentralPubMed
133.
Zurück zum Zitat Lado FA, Moshe SL. Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators? Int Rev Neurobiol 2002;49:115-140.PubMed Lado FA, Moshe SL. Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators? Int Rev Neurobiol 2002;49:115-140.PubMed
134.
Zurück zum Zitat Briggs SW, Mowrey W, Hall CB, Galanopoulou AS. CPP-115, a vigabatrin analogue, suppresses spasms in the multiple-hit rat model of infantile spasms. Epilepsia 2014;55:94-102.PubMed Briggs SW, Mowrey W, Hall CB, Galanopoulou AS. CPP-115, a vigabatrin analogue, suppresses spasms in the multiple-hit rat model of infantile spasms. Epilepsia 2014;55:94-102.PubMed
135.
Zurück zum Zitat Ono T, Moshe SL, Galanopoulou AS. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. Epilepsia 2011;52:1678-1684.PubMedCentralPubMed Ono T, Moshe SL, Galanopoulou AS. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. Epilepsia 2011;52:1678-1684.PubMedCentralPubMed
136.
Zurück zum Zitat Jequier Gygax M, Klein BD, White HS, Kim M, Galanopoulou AS. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms. Epilepsy Res 2014;108:98-108.PubMed Jequier Gygax M, Klein BD, White HS, Kim M, Galanopoulou AS. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms. Epilepsy Res 2014;108:98-108.PubMed
137.
Zurück zum Zitat van Baalen A, Hausler M, Boor R, Rohr A, Sperner J, Kurlemann G, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010;51:1323-1328.PubMed van Baalen A, Hausler M, Boor R, Rohr A, Sperner J, Kurlemann G, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010;51:1323-1328.PubMed
138.
Zurück zum Zitat Mikaeloff Y, Jambaque I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006;69:67-79.PubMed Mikaeloff Y, Jambaque I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006;69:67-79.PubMed
139.
Zurück zum Zitat Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676-685.PubMed Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 2010;51:676-685.PubMed
140.
Zurück zum Zitat Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011;10:99-108.PubMed Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011;10:99-108.PubMed
141.
Zurück zum Zitat Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011;52:1956-1965.PubMed Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011;52:1956-1965.PubMed
142.
Zurück zum Zitat Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia 2011;52(Suppl. 8):28-30.PubMed Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia 2011;52(Suppl. 8):28-30.PubMed
143.
Zurück zum Zitat Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033-2037.PubMed Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033-2037.PubMed
144.
Zurück zum Zitat Villeneuve N, Pinton F, Bahi-Buisson N, Dulac O, Chiron C, Nabbout R. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol 2009;51:276-281.PubMed Villeneuve N, Pinton F, Bahi-Buisson N, Dulac O, Chiron C, Nabbout R. The ketogenic diet improves recently worsened focal epilepsy. Dev Med Child Neurol 2009;51:276-281.PubMed
145.
Zurück zum Zitat Mazzuca M, Jambaque I, Hertz-Pannier L, et al. 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011;52:40-47.PubMed Mazzuca M, Jambaque I, Hertz-Pannier L, et al. 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011;52:40-47.PubMed
146.
Zurück zum Zitat Bindoff LA, Engelsen BA. Mitochondrial diseases and epilepsy. Epilepsia 2012;53(Suppl. 4):92-97.PubMed Bindoff LA, Engelsen BA. Mitochondrial diseases and epilepsy. Epilepsia 2012;53(Suppl. 4):92-97.PubMed
147.
Zurück zum Zitat Appenzeller S, Helbig I, Stephani U, et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol 2012;54:1144-1148.PubMed Appenzeller S, Helbig I, Stephani U, et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol 2012;54:1144-1148.PubMed
148.
Zurück zum Zitat Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009;5:e1000381.PubMedCentralPubMed Depienne C, Bouteiller D, Keren B, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009;5:e1000381.PubMedCentralPubMed
149.
Zurück zum Zitat Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012;44:1255-1259.PubMedCentralPubMed Barcia G, Fleming MR, Deligniere A, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 2012;44:1255-1259.PubMedCentralPubMed
150.
Zurück zum Zitat Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009;41:160-162.PubMedCentralPubMed Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009;41:160-162.PubMedCentralPubMed
151.
Zurück zum Zitat Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005;95:71-102.PubMed Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005;95:71-102.PubMed
152.
Zurück zum Zitat Specchio N, Fusco L, Claps D, Vigevano F. Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Develop 2010;32:51-56. Specchio N, Fusco L, Claps D, Vigevano F. Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Develop 2010;32:51-56.
153.
Zurück zum Zitat Specchio N, Fusco L, Vigevano F. Acute-onset epilepsy triggered by fever mimicking FIRES (febrile infection-related epilepsy syndrome): the role of protocadherin 19 (PCDH19) gene mutation. Epilepsia 2011;52:e172-5.PubMed Specchio N, Fusco L, Vigevano F. Acute-onset epilepsy triggered by fever mimicking FIRES (febrile infection-related epilepsy syndrome): the role of protocadherin 19 (PCDH19) gene mutation. Epilepsia 2011;52:e172-5.PubMed
154.
Zurück zum Zitat Carranza Rojo D, Hamiwka L, McMahon JM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology 2011;77:380-383.PubMedCentralPubMed Carranza Rojo D, Hamiwka L, McMahon JM, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology 2011;77:380-383.PubMedCentralPubMed
155.
Zurück zum Zitat van Baalen A, Hausler M, Plecko-Startinig B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 2012;43:209-216.PubMed van Baalen A, Hausler M, Plecko-Startinig B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 2012;43:209-216.PubMed
156.
Zurück zum Zitat Ravizza T, Kostoula C, Vezzani A. Immunity activation in brain cells in epilepsy: mechanistic insights and pathological consequences. Neuropediatrics 2013;44:330-335.PubMed Ravizza T, Kostoula C, Vezzani A. Immunity activation in brain cells in epilepsy: mechanistic insights and pathological consequences. Neuropediatrics 2013;44:330-335.PubMed
Metadaten
Titel
Mechanisms of Epileptogenesis in Pediatric Epileptic Syndromes: Rasmussen Encephalitis, Infantile Spasms, and Febrile Infection-related Epilepsy Syndrome (FIRES)
verfasst von
Carlos A. Pardo
Rima Nabbout
Aristea S. Galanopoulou
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Neurotherapeutics / Ausgabe 2/2014
Print ISSN: 1933-7213
Elektronische ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-014-0265-2

Weitere Artikel der Ausgabe 2/2014

Neurotherapeutics 2/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.